51655-0933 Ondansetron Hydrochloride

Product NDC:

51655-0933

Brand Name:

Ondansetron Hydrochloride

Generic Name:

Ondansetron Hydrochloride

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: ONDANSETRON HYDROCHLORIDE

Strength: 4.0

Unit: mg/1

Packages:

Code: 51655-0933-04

Description: 4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-933-04)

Effective Date: Oct. 25, 2022

Discontinued:

Code: 51655-0933-43

Description: 3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-933-43)

Effective Date: July 20, 2022

Discontinued:

Code: 51655-0933-53

Description: 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-933-53)

Effective Date: Sept. 16, 2022

Discontinued:

Code: 51655-0933-87

Description: 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-933-87)

Effective Date: July 20, 2022

Discontinued:

Code: 51655-0933-54

Description: 15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-933-54)

Effective Date: May 11, 2023

Discontinued:

Code: 51655-0933-55

Description: 5 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-933-55)

Effective Date: May 9, 2023

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC